WallStreetZenWallStreetZen

NASDAQ: POAI
Predictive Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their POAI stock forecasts and price targets.

Forecast return on equity

Is POAI forecast to generate an efficient return?

Company
-12.1%
Industry
20.17%
Market
268.35%
POAI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is POAI forecast to generate an efficient return on assets?

Company
5.82%
Industry
14.98%
POAI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

POAI earnings per share forecast

What is POAI's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.13
Avg 2 year Forecast
$0.08
Avg 3 year Forecast
$0.28

POAI revenue forecast

What is POAI's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$9.5M+789.5%
Avg 2 year Forecast
$15.8M+1,372.16%
Avg 3 year Forecast
$24.4M+2,184.3%
POAI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

POAI revenue growth forecast

How is POAI forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
293.53%
Industry
7.83%
Market
58.52%
POAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
POAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

POAI vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
POAI$8.46N/AN/A
GCTK$6.43N/AN/A
MHUA$0.24N/AN/A
STSS$4.50N/AN/A
LUCY$1.72N/AN/A
View Top Medical Stocks

Predictive Oncology Stock Forecast FAQ

What is POAI's earnings growth forecast for 2025-2027?

(NASDAQ: POAI) Predictive Oncology's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 23.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 102.26%.

Predictive Oncology's earnings in 2025 is -$9,777,619.On average, 3 Wall Street analysts forecast POAI's earnings for 2025 to be -$96,289, with the lowest POAI earnings forecast at -$92,513, and the highest POAI earnings forecast at -$99,121. On average, 3 Wall Street analysts forecast POAI's earnings for 2026 to be $59,255, with the lowest POAI earnings forecast at $56,931, and the highest POAI earnings forecast at $60,998.

In 2027, POAI is forecast to generate $199,985 in earnings, with the lowest earnings forecast at $192,142 and the highest earnings forecast at $205,867.

If you're new to stock investing, here's how to buy Predictive Oncology stock.

What is POAI's revenue growth forecast for 2025-2027?

(NASDAQ: POAI) Predictive Oncology's forecast annual revenue growth rate of 293.53% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.83%, and it is also forecast to beat the US market's average forecast revenue growth rate of 58.52%.

Predictive Oncology's revenue in 2025 is $1,070,263.On average, 3 Wall Street analysts forecast POAI's revenue for 2025 to be $6,913,062, with the lowest POAI revenue forecast at $6,641,478, and the highest POAI revenue forecast at $7,116,388. On average, 3 Wall Street analysts forecast POAI's revenue for 2026 to be $11,441,408, with the lowest POAI revenue forecast at $10,992,640, and the highest POAI revenue forecast at $11,777,621.

In 2027, POAI is forecast to generate $17,753,209 in revenue, with the lowest revenue forecast at $17,057,545 and the highest revenue forecast at $18,275,319.

What is POAI's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: POAI) forecast ROA is 5.82%, which is lower than the forecast US Medical Instruments & Supplies industry average of 14.98%.

What is POAI's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: POAI) Predictive Oncology's current Earnings Per Share (EPS) is -$19.35. On average, analysts forecast that POAI's EPS will be -$0.13 for 2025, with the lowest EPS forecast at -$0.13, and the highest EPS forecast at -$0.14. On average, analysts forecast that POAI's EPS will be $0.08 for 2026, with the lowest EPS forecast at $0.08, and the highest EPS forecast at $0.08. In 2027, POAI's EPS is forecast to hit $0.28 (min: $0.26, max: $0.28).

What is POAI's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: POAI) forecast ROE is -12.1%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.